Last reviewed · How we verify

NCT04913194: ARFID-PTP

A Two-Session Exposure Treatment and Parent Training for ARFID

Status unknown NA Last updated 16 June 2022
What this trial tests

NA trial testing ARFID-PTP in Avoidant Restrictive Food Intake Disorder in 40 participants. Status unknown.

Timeline
15 February 2021
Primary endpoint
31 December 2022
15 June 2023

Quick facts

Lead sponsorUniversity at Albany
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date15 February 2021
Primary completion31 December 2022
Estimated completion15 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University at Albany

Who can join

Adults 5 to 12, any sex, with Avoidant Restrictive Food Intake Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the acceptability, feasibility, and preliminary efficacy of a two-session, virtual parent-training exposure protocol for children ages 5-12 who experience picky eating consistent with an Avoidant-Restrictive Food Intake Disorder (ARFID) diagnosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. ARFID Parent Training Protocol ("ARFID-PTP"): Results of a Randomized Pilot Trial Evaluating a Brief, Parent-Training Program for Avoidant/Restrictive Food Intake Disorder.
    Breiner CE, Miller ML, Hormes JM. · · 2024 · cited 5× · PMID 39031449 · DOI 10.1002/eat.24269

Verify or expand the search:

Other recruiting trials for Avoidant Restrictive Food Intake Disorder

Currently open trials in the same condition.

Other University at Albany trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04913194.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing